MZT1 as a Prognostic and Immune-related Biomarker Promoting Invasion and Metastasis in Lung Adenocarcinoma

Zhaoting Hu, Yuxin Chen, Yixin Chen, Jiali Fu, Yumin Wang

Open source

DOI
10.2174/0115680096525364261015054912
Published
2026-10-19
Container
Current Cancer Drug Targets
Publisher
Bentham Science Publishers Ltd.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0115680096525364261015054912,
  title = {MZT1 as a Prognostic and Immune-related Biomarker Promoting Invasion and Metastasis in Lung Adenocarcinoma},
  author = {Zhaoting Hu and Yuxin Chen and Yixin Chen and Jiali Fu and Yumin Wang},
  year = {2026},
  journal = {Current Cancer Drug Targets},
  doi = {10.2174/0115680096525364261015054912},
  url = {https://doi.org/10.2174/0115680096525364261015054912}
}

RIS

TY  - JOUR
TI  - MZT1 as a Prognostic and Immune-related Biomarker Promoting Invasion and Metastasis in Lung Adenocarcinoma
AU  - Zhaoting Hu
AU  - Yuxin Chen
AU  - Yixin Chen
AU  - Jiali Fu
AU  - Yumin Wang
PY  - 2026
JO  - Current Cancer Drug Targets
DO  - 10.2174/0115680096525364261015054912
UR  - https://doi.org/10.2174/0115680096525364261015054912
ER  - 

APA

Hu, Z., Chen, Y., Chen, Y., Fu, J., & Wang, Y. (2026). MZT1 as a Prognostic and Immune-related Biomarker Promoting Invasion and Metastasis in Lung Adenocarcinoma. Current Cancer Drug Targets. https://doi.org/10.2174/0115680096525364261015054912

Source records